Adherex Reports Q3 2006 Financial Results
14th Nov 2006, 16:02 GMT
Adherex Technologies, a biopharmaceutical company with a broad portfolio of oncology products under development, reported its financial results for Q3 ended 9/30/2006.
Adherex Reports Q3 2006 Financial Results related news:
- Adherex Reports Third Quarter 2006 Financial Results — ArriveNet : Press Releases
- Adherex Technologies Inc.: Adherex Reports Third Quarter 2006 Financial Results — Market Wire - Medical and Healthcare
- Favrille Reports Q3 2006 Financial Results — StratWire - Business of Healthcare NewsFeed
- BioSante Pharmaceuticals Reports Q3 2006 Financial Results And Reviews Bio-E-Gel Marketing Agreement — Operations-Related News from StratCenter.com
- Nymox Reports Q3 2006 Financial Results — Pharmaceuticals News from StratCenter.com
- Aksys Reports Q3 2006 Financial Results — Nephrology/ Dialysis News from StratCenter.com
- Alexza Reports Q3 Financial Results and Updates Status of Development Pipeline — StratWire - Business of Healthcare NewsFeed
- Stratagene Reports Q3 Results — Laboratory News from StratCenter.com
- Cardiogenesis Reports Q3 2006 Results — Surgery News from StratCenter.com
- Chelsea Therapeutics Reports Q3 2006 Results — Operations-Related News from StratCenter.com
Latest news from Radiology News from StratCenter.com:
- Genzyme increasing R&D presence in San Antonio area
- Eisai Breaks Ground for New Oncology Facility in Research Triangle Park
- Ashok Gupta, MD Joins the Physician Team at Desert Radiologists
- AMICAS Offers Free PACS Webinar for RSNA Attendees
- Enrollment Completed Utilizing Cytori's Adipose-Derived Stem Cell Technology for Treatment of Breast Cancer Complications
- Groundbreaking for Cancer Center on Premier Healh Campus - Middletown
- BSD Medical Sends Message of Hope at Largest Conference of US Radiation Oncologists
- Volcano to Offer 7.5M Shares
- Nautilus Biotech and Creabilis Therapeutics Achieve Technical Milestone in Collaboration to Improve HMGB1 Box A for the Treatment of Rage- and HMGB1-Related Pathologies.
- Stereotaxis to Present at Bear Stearns 2006 SMid-Cap Investor Conference